Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
Benralizumab 30 Mg/ml Sol [Kchs] (CDM 103227063) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved June 30, 2026 , from http://ppman.hank.ai/transparency/procedure/103227063/by-state?code_type=CDM
“Benralizumab 30 Mg/ml Sol [Kchs] (CDM 103227063) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/103227063/by-state?code_type=CDM. Accessed
June 30, 2026 .
“Benralizumab 30 Mg/ml Sol [Kchs] (CDM 103227063) by State,” HANK Price Transparency ,
accessed June 30, 2026 ,
http://ppman.hank.ai/transparency/procedure/103227063/by-state?code_type=CDM.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
CDM · across United States
103227063 — Benralizumab 30 Mg/ml Sol [Kchs]
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$9,380
National median
$6,755 – $13,906
IQR (p25 – p75)
1
hospitals filing
1
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 103227063 (CDM), with interquartile range
State Median p25 p75
KS $9,380 $6,755 $13,906